Non-alcoholic fatty liver disease: An emerging liver disease in Taiwan

被引:30
|
作者
Hsu, Ching-Sheng [1 ,2 ,3 ,4 ]
Kao, Jia-Horng [1 ,4 ,5 ,6 ,7 ]
机构
[1] Natl Taiwan Univ, Coll Med, Grad Inst Clin Med, Taipei 10002, Taiwan
[2] Buddhist Tzu Chi Gen Hosp, Dept Internal Med, Div Gastroenterol, Taipei Branch, Taipei, Taiwan
[3] Tzu Chi Univ, Sch Med, Hualien, Taiwan
[4] Natl Taiwan Univ Hosp, Taipei, Taiwan
[5] Natl Taiwan Univ, Coll Med, Dept Med Res, Taipei 10002, Taiwan
[6] Natl Taiwan Univ, Coll Med, Hepatitis Res Ctr, Taipei 10002, Taiwan
[7] Natl Taiwan Univ, Coll Med, Dept Internal Med, Taipei 10002, Taiwan
关键词
fatty liver; hepatitis B virus; hepatitis C virus; metabolic syndrome; NASH; Taiwan; ASIA-PACIFIC REGION; CHRONIC HEPATITIS-C; INSULIN-RESISTANCE; METABOLIC SYNDROME; RISK-FACTORS; HEPATOCELLULAR-CARCINOMA; LIPID-PEROXIDATION; ADULT-POPULATION; DIAGNOSTIC-VALUE; CHINESE PATIENTS;
D O I
10.1016/j.jfma.2012.07.002
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Non-alcoholic fatty liver disease (NAFLD) is the most common liver disorder in Western countries, and has become increasingly recognized as a public health problem in Taiwan. Patients with non-alcoholic steatohepatitis, a more severe form of NAFLD, may progress to cirrhosis and its related complications, including hepatocellular carcinoma. Since NAFLD is highly linked to metabolic syndrome, such patients may have increased risks of complications related to both liver disease and metabolic syndrome. Therefore, if we fail to cope with this growing health problem, NAFLD may gradually replace viral hepatitis as the major etiology of liver disease in Taiwan. Copyright (C) 2012, Elsevier Taiwan LLC & Formosan Medical Association. All rights reserved.
引用
收藏
页码:527 / 535
页数:9
相关论文
共 50 条
  • [1] Emerging drugs for non-alcoholic fatty liver disease
    Federico, Alessandro
    Niosi, Marco
    Blanco, Camillo Del Vecchio
    Loguercio, Carmela
    [J]. EXPERT OPINION ON EMERGING DRUGS, 2008, 13 (01) : 145 - 158
  • [2] Non-alcoholic fatty liver disease: beyond the liver is an emerging multifaceted systemic disease
    Adinolfi, Luigi Elio
    Marrone, Aldo
    Rinaldi, Luca
    [J]. HEPATOBILIARY SURGERY AND NUTRITION, 2018, 7 (02) : 143 - 146
  • [3] Emerging Diagnostics and Therapeutics for Non-alcoholic Fatty Liver Disease
    Darbhanga, Jake
    Krulikowski, Kiarra
    Riskin, Suzanne I.
    [J]. CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (10)
  • [4] Current and Emerging Therapies for Non-alcoholic Fatty Liver Disease
    Patel, Samarth Siddharth
    Siddiqui, Mohammad Shadab
    [J]. DRUGS, 2019, 79 (01) : 75 - 84
  • [5] Current and Emerging Therapies for Non-alcoholic Fatty Liver Disease
    Samarth Siddharth Patel
    Mohammad Shadab Siddiqui
    [J]. Drugs, 2019, 79 : 75 - 84
  • [6] Non-alcoholic fatty liver disease: an emerging pathological spectrum
    Elie Serge Zafrani
    [J]. Virchows Archiv, 2004, 444 : 3 - 12
  • [7] Non-alcoholic fatty liver disease: an emerging pathological spectrum
    Zafrani, ES
    [J]. VIRCHOWS ARCHIV, 2004, 444 (01) : 3 - 12
  • [8] Non-alcoholic fatty liver disease
    Angulo, P
    Lindor, KD
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2002, 17 : S186 - S190
  • [9] Non-alcoholic Fatty Liver Disease
    Tan, Hui-Hui
    Chang, Jason Pik-Eu
    [J]. PROCEEDINGS OF SINGAPORE HEALTHCARE, 2010, 19 (01) : 36 - 50
  • [10] Emerging concepts in the detection of liver fibrosis in non-alcoholic fatty liver disease
    Armandi, Angelo
    Michel, Maurice
    Gjini, Kamela
    Emrich, Tilman
    Bugianesi, Elisabetta
    Schattenberg, Jorn M. M.
    [J]. EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 2023, : 771 - 782